SCLX
Scilex Holding CompanyNASDAQHealthcare$7.44+7.67%ClosedMarket Cap: $63.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.49
P/S
1.57
EV/EBITDA
-0.40
DCF Value
$-186.62
FCF Yield
37.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
68.6%
Operating Margin
-652.4%
Net Margin
-931.2%
ROE
181.1%
ROA
-162.0%
ROIC
948.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $10.6M | 68.5% | $-186.5M | $-257.2M | $-22.17 | — |
| Q2 2025 | $9.9M | 66.9% | $-20.5M | $-86.1M | $-7.42 | — |
| Q1 2025 | $5.0M | 72.3% | $-27.9M | $-26.1M | $-2.26 | — |
| Q4 2024 | $14.9M | 68.5% | $-28.4M | $-6.5M | $-1.23 | — |
| FY 2024 | $56.6M | 70.5% | $-83.4M | $-72.8M | $-19.43 | — |
| Q3 2024 | $14.4M | 73.9% | $-19.9M | $-4.4M | $-1.21 | — |
| Q2 2024 | $16.4M | 73.2% | $-15.6M | $-37.6M | $-10.94 | — |
| Q1 2024 | $10.9M | 64.7% | $-19.5M | $-24.4M | $-6.69 | — |
| Q4 2023 | $13.5M | 58.7% | $-18.3M | $-21.4M | $-7.49 | — |
| FY 2023 | $46.7M | 66.5% | $-105.4M | $-114.3M | $-44.85 | — |
| Q3 2023 | $10.1M | 66.5% | $-38.8M | $-35.5M | $-8.89 | — |
| Q2 2023 | $12.6M | 66.8% | $-22.8M | $-26.6M | $-0.19 | — |